BAUSCH + LOMB CORP. Share Price Today: Live Updates & Key Insights

BAUSCH + LOMB CORP. share price today is $15.72, up -2.78%. The stock opened at $16.23 against the previous close of $16.17, with an intraday high of $16.3 and low of $15.61.

BAUSCH + LOMB CORP. Share Price Chart

BAUSCH + LOMB CORP.

us-stock
To Invest in {{usstockname}}
us-stock

BAUSCH + LOMB CORP. Share Price Performance

$15.72 -0.0278(-2.78%) BLCO at 23 Mar 2026 12:14 PM Medical Instruments & Supplies
Lowest Today 15.61
Highest Today 16.3
Today’s Open 16.23
Prev. Close 16.17
52 Week High 18.92
52 Week Low 10.45
Day’s Range: Low 15.61 High 16.3
52-Week Range: Low 10.45 High 18.92
1 day return -
1 Week return -4.49
1 month return -12.22
3 month return -6.92
6 month return +3.07
1 year return -1.13
3 year return -2.17
5 year return -
10 year return -

BAUSCH + LOMB CORP. Institutional Holdings

Deutsche Bank AG 0.99

ICAHN CARL C 0.99

Oaktree Capital Management LLC 0.95

D. E. Shaw & Co LP 0.80

Goldentree Asset Management LP 0.75

Silver Point Capital LP 0.72

Caspian Capital Partners, L.P. 0.56

Davidson Kempner Capital Management LP 0.55

Glenview Capital Management LLC 0.47

FMR Inc 0.41

Nomura Holdings Inc 0.35

T. Rowe Price Associates, Inc. 0.35

Diameter Capital Partners LP 0.34

Arrowstreet Capital Limited Partnership 0.34

Fidelity Tactical High Income Sr F8 0.27

Whitebox Advisors, LLC 0.27

Citadel Advisors Llc 0.26

Compass Rose Asset Management LP 0.25

Clearline Capital LP 0.23

Clark Estates Inc 0.23

Woodline Partners LP 0.22

T. Rowe Price High Yield 0.16

T. Rowe Price High Yield Bond 0.16

Loomis Sayles MFD Class C 0.16

T. Rowe Price Glb High Inc Bd I 0.14

Fidelity Advisor Multi-Asset Income I 0.14

T. Rowe Price High Yield Trust - D 0.08

Bestinver Norteamérica FI 0.07

Bestinver Grandes Compañías FI 0.05

Ballast Small/Mid Cap ETF 0.04

T. Rowe Price Instl High Yield 0.04

Ballast SMidCap 0.04

Gabelli Health & Wellness 0.04

Gabelli Dividend & Income 0.03

T. Rowe Price Glbl HY Opps Bd C Inc Q 9 0.03

Pleiades Small Cap Equity A 0.02

T. Rowe Price Global High Inc Full Auth 0.02

T. Rowe Price Global High Income Bd 0.02

CI Alternative Diversified Opp Y 0.01

T. Rowe Price Global Hi Yld Bd A 0.01

BAUSCH + LOMB CORP. Market Status

Strong Buy: 3

Buy: 3

Hold: 8

Sell: 1

Strong Sell: 0

BAUSCH + LOMB CORP. Fundamentals

Market Cap 5581.83 M

PB Ratio 0.8638

PE Ratio 0.0

Enterprise Value 10411.99 M

Total Assets 14022.00 M

Volume 388521

BAUSCH + LOMB CORP. Company Financials

Annual Revenue FY25:5101000000 5101.0M, FY24:4774000000 4774.0M, FY23:3969000000 3969.0M, FY22:3768000000 3768.0M, FY21:3765000000 3765.0M

Annual Profit FY25:2995000000 2995.0M, FY24:2902000000 2902.0M, FY23:2368000000 2368.0M, FY22:2249000000 2249.0M, FY21:2298000000 2298.0M

Annual Net worth FY25:-360000000 -360.0M, FY24:-317000000 -317.0M, FY23:-207000000 -207.0M, FY22:15000000 15.0M, FY21:182000000 182.0M

Quarterly Revenue Q4/2025:1405000000 1405.0M, Q3/2025:1281000000 1281.0M, Q2/2025:1278000000 1278.0M, Q1/2025:1137000000 1137.0M, Q4/2024:1280000000 1280.0M

Quarterly Profit Q4/2025:816000000 816.0M, Q3/2025:771000000 771.0M, Q2/2025:753000000 753.0M, Q1/2025:655000000 655.0M, Q4/2024:779000000 779.0M

Quarterly Net worth Q4/2025:-58000000 -58.0M, Q3/2025:-28000000 -28.0M, Q2/2025:-62000000 -62.0M, Q1/2025:-212000000 -212.0M, Q4/2024:-3000000 -3.0M

About BAUSCH + LOMB CORP. & investment objective

Company Information Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Organisation Medical Instruments & Supplies

Employees 13000

Industry Medical Instruments & Supplies

CEO Mr. Brenton L. Saunders J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BAUSCH + LOMB CORP. FAQs

What is the share price of BAUSCH + LOMB CORP. today?

The current share price of BAUSCH + LOMB CORP. is $15.72.

Can I buy BAUSCH + LOMB CORP. shares in India?

Yes, Indian investors can buy BAUSCH + LOMB CORP. shares by opening an international trading and demat account with Motilal Oswal.

How to buy BAUSCH + LOMB CORP. shares in India?

You can easily invest in BAUSCH + LOMB CORP. shares from India by:

Can I buy fractional shares of BAUSCH + LOMB CORP.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BAUSCH + LOMB CORP.?

BAUSCH + LOMB CORP. has a market cap of $5581.83 M.

In which sector does BAUSCH + LOMB CORP. belong?

BAUSCH + LOMB CORP. operates in the Medical Instruments & Supplies sector.

What documents are required to invest in BAUSCH + LOMB CORP. stocks?

To invest, you typically need:

What is the PE and PB ratio of BAUSCH + LOMB CORP.?

The PE ratio of BAUSCH + LOMB CORP. is N/A and the PB ratio is 0.86.